Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy

A novel, biocompatible, hybrid nanoplatform is developed to seek and treat cancer in vivo. [(89)Zr]-labeled HMSN shell, CuS nanosatellites and photosensitizer porphyrin, self-assemble into a high-performance nanotheranostic agent that integrates positron emission tomography, fluorescence, Cerenkov L...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Adv Mater
Autors principals: Goel, Shreya, Ferreira, Carolina A., Chen, Feng, Ellison, Paul A., Siamof, Cerise M., Barnhar, Todd E., Cai, Weibo
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805572/
https://ncbi.nlm.nih.gov/pubmed/29266476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adma.201704367
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars